| Abstract This TriMark Publications report
examines the disposable syringe markets as well as the supplies
utilized in clinics and by patients directly in their homes to diagnose
and monitor disease and to administer medications. This analysis
is intended to provide basic market data pertaining to the U.S.
and worldwide market segments. Each market segment is analyzed to
determine size, growth rates, sales projections and factors influencing
growth in the U.S. and internationally.
Please note: Trimark uses a digital rights management tool to distribute
their reports. The client will need to download SealedMedia viewer
before the client will be able to access the secured PDF files.
Upon ordering an electronic version, the Publisher will provide
a link to download the software and the purchased report.
Table of Contents
1. Introduction
1.1 Statement of Report
1.2 About This Report
1.3 Scope of the Report
1.4 Objectives
1.5 Methodology
1.6 Executive Summary
2. Disposable Syringe Markets
2.1 Overview
2.2 Infection Control and Safety
2.3 Hospital Consolidations Pressure Companies to Reduce Prices
2.4 Needleless Injector Manufacturers Forge Strategic Alliances
2.5 Technological Advancements in Disposable Syringes
3. Syringe Market Segments
3.1 Overview
3.1.1 World Market
3.1.2 U.S. Market
3.2 Total Reusable Needle and Syringe Market
3.3 Total Disposable Needle and Syringe Market
3.4 Prefilled Syringes
3.5 Insulin Injector Pens
3.6 Needleless Injectors
3.7 Vaccination Injectors
3.8 Needle and Syringe Market Trends
3.8.1 Market Segments
3.8.2 Customer Needs
3.8.3 Competitor Analysis
3.8.4 Target Markets for Specialty Syringes
3.8.5 Third-Party Reimbursement
3.8.6 Regulation
3.8.7 Drug Discovery Trends
3.8.8 Demographic Shifts
3.8.9 Managed Care Initiatives
3.8.10 Growth in Home Healthcare
4. Technology Development and Sterilization Methods
4.1 Disposable Syringes
4.1.1 Autodestruct Syringes
4.1.2 SoloShot™
4.2 Monodose Syringes
4.3 Prefilled Syringes
4.3.1 Features of Prefilled Membrane Syringes
4.3.2 Pen Syringes
4.3.2.1 Technical Advances in Pens
4.3.2.2 Advantages of Pens
4.3.2.3 Pen Types and Styles
4.3.2.4 Prefilled Pens
4.3.2.5 Reusable Pens
4.3.2.6 Device Preparation
4.3.2.7 Autopen
4.3.2.8 Unifine Pentips
4.3.3 Autoject 2
4.4 Insulin Syringes
4.5 Jet Injectors
4.6 Insulin Pens
4.7 Uniject™ Injection Device
4.8 Microneedle
4.9 Needle-Free Injection
4.9.1 Hypospray
4.10 Glass Prefillable Syringes
4.11 Retractable Syringe
4.12 Ultrasafe Passive Delivery Systems
4.13 Ultrasmall Syringes and Microsyringes
4.14 Tip-Lok® Syringes
4.15 Product Profiles
4.15.1 Gettig Guard™
4.15.2 Inviro SNAP! ®
4.15.3 Maxxon Safety Syringe
4.15.4 Monoject Magellan™
4.15.5 Needle-Pro
4.15.6 Point-Lok®
4.15.7 SafetyGlide™
4.16 SC Injection Technology
5. Business Trends
5.1 Market Drivers
5.2 Market Prospects
5.3 Marketing and Distribution
5.4 Competitive Landscape
5.5 Business Developments
5.6 Acquisitions and Partnerships
5.7 Key Players
5.7.1 Kendall
5.7.2 Becton Dickinson
5.7.3 C.R. Bard
5.7.4 International Medication Systems
5.7.5 Terumo Medical Corporation
6. Future Technologies
6.1 Thermostable Vaccines and Vaccine Vial Monitors
6.2 Sugar Glass
6.3 Issues in Technology Transfer for AD Syringes
7. Regulatory Measures
7.1 Safety Syringes in Europe
7.2 Safety Syringe Regulations and Recommendations
7.3 Reimbursement Outlook for Injectables
8. Corporate Profiles
9. Corporate Directory
Appendix 1: FDA-Approved Syringe Manufacturers
Appendix 2: NAPPSI Primary and Secondary Prevention: Needlestick
Safety Device List
Appendix 3: Ambulatory Care Services OSHA/Safety Device Listing
INDEX OF FIGURES
Figure 1. U.S. Safety Needle and Syringe Market
Figure 2. Strategy of the “Sugar Project”
INDEX OF TABLES
Table 1: Global Market for Injection Devices
Table 2: Global Market for Needles and Syringes
Table 3: Global Market for Injection Devices by Category, 2004
Table 4: Worldwide Dollar Market for Needles and Syringes
Table 5: Worldwide Unit Market for Needles and Syringes
Table 6: U.S. Dollar Market for Needles and Syringes
Table 7: Worldwide Disposable Needle and Syringe Market, 1998-2006
Table 8: Worldwide Market for Disposable Needles and Syringes by
Region 2004
Table 9: Worldwide Safety Syringe Unit Sales, 1998-2006
Table 10: Worldwide Safety Syringe Dollar Volume, 1998-2006
Table 11: Share of Worldwide Safety Syringes Market by Competitor
Table 12: Share of Worldwide Market for Safety Syringes by Region
Table 13: Worldwide Prefilled Syringe Unit Sales, 1998-2006
Table 14: Worldwide Prefilled Syringe Dollar Volume, 1998-2006
Table 15: Share of Worldwide Prefilled Syringe Market by Competitor
Table 16: Share of Worldwide Market for Prefilled Syringes by Region
Table 17: Worldwide Insulin Injector Pen Dollar Volume, 1998-2006
Table 18: Worldwide Market for Needle-Free Injectable Drug Delivery
Systems
Table 19: Worldwide Needleless Injector Dollar Volume, 1998-2006
Table 20: Worldwide Vaccination Injector Unit Sales, 1998-2006
Table 21: Share of Worldwide Market for Vaccination Injectors by
Region
Table 22: Worldwide Vaccination Injector Dollar Volume, 1998-2006
Table 23: Share of Worldwide Vaccination Injector Market by Competitor
Table 24: Summary of Strengths and Weaknesses of Available Syringes
Table 25: Annual Change Per Capita in Healthcare Spending and Gross
Domestic Product, 1994-2004 33
Table 26: Injection Data Using Soloshot and Disposable Syringes
Table 27: Summary Data for Doses by Soloshot and Disposable Syringes
Table 28: Wastage Analysis (Per Vial Used)
Table 29: Important Injectable Drug Therapies Using Prefilled Devices
Table 30: Regionwise Market of Prefilled Syringes
Table 31: Worldwide Prefilled Syringe Unit Sales, 1998-2006
Table 32: Worldwide Prefilled Syringe Dollar Volume, 1998-2004
Table 33: Insulin Delivery Systems Percent Retail Market Share
Table 34: Insulin Delivery Systems Percent Retail Market Share by
Company
Table 35: Commonly-Available Insulin Syringes
Table 36: Features of Available Insulin Pumps
Table 37: Features of Available Jet Injectors
Table 38: Currently-Available Insulin Delivery Pens
Table 39: Summary of Clinical and Field Experience with the Uniject
Device
Table 40: Comparative System Costs of Hepatitis B Presentations
and Injection Devices
Table 41: Novo Nordisk Global Sales |